DIVIS LABORATORIES LTD.

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals & DrugsHouse : Divis Labs
BSE1503.701.3 (+0.09 %)
PREV CLOSE ( ) 1502.40
OPEN PRICE ( ) 1502.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10891
TODAY'S LOW / HIGH ( )1496.80 1511.80
52 WK LOW / HIGH ( )978.5 1577
NSE1503.30-0.35 (-0.02 %)
PREV CLOSE( ) 1503.65
OPEN PRICE ( ) 1508.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1503.30 (53)
VOLUME 302963
TODAY'S LOW / HIGH( ) 1496.05 1512.55
52 WK LOW / HIGH ( )978.35 1578
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 12-10 1990
Management Info
Murali K Divi - Chairman Murali K Divi - Managing Director
Registered Office

Address 1-72/23(p)/divis/303,Divi Towers, Cyber Hills,Gachibowli,
Hyderabad,
Telangana-500032

Phone 040 2378 6300

Email mail@divislaboratories.com

Website www.divislaboratories.com

Registrars Details
Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
26Dec Loss of Share Certificate / Issue of
Divis Laboratories Ltd has informed BSE regarding Loss of Share Certific..
03Dec Transfer Of Operations Of RTA
Transfer of operations of Registrar & Share Transfer Agent from Karvy Co..
12Jul Divis Laboratories submits shareholdin
Divis Laboratories has submitted the Shareholding Pattern for the Period..
17May Infosys, Divis Laboratories and Zensar
Infosys Finacle, part of EdgeVerve Systems, a wholly-owned subsidiary of..
17May USFDA inspects Divis Laboratories’ fac
Divis Laboratories’ Unit-I at Choutuppal in state of Telangana has been..
Financials
Rs. in Millions
QTR Sep 18 ANNUAL 18
Net Profit3976.58695.8
Gross Profit 5515.5 12193.6
Operating Profit 5941.813631.1
Net Sales 1285038372.3
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Astrazeneca Pharma I (BSE)
 1650.90 (2.65%)
M.Cap (Rs. in Cr)4127.25
Piramal Enterprises (BSE)
 2360.25 (1.09%)
M.Cap (Rs. in Cr)43333.78
Fredun Pharma (BSE)
 400.30 (5.91%)
M.Cap (Rs. in Cr)159.71
TTK Healthcare (BSE)
 770.30 (2.03%)
M.Cap (Rs. in Cr)1088.46
Sun Pharma Inds. (BSE)
 430.75 (3.04%)
M.Cap (Rs. in Cr)103351.07
Shareholding Pattern
PROMOTERS 52.01%
MUTUAL FUNDS/UTI 14.62%
NON-INSTITUTION 13.01%
FI/BANKS/INSURANCE 0.33%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal,Apurva Mittal, Tel no: 022-40790032,022 - 40790024, Mobile no- 9773104340,9768009000 E-mail id- Complaince@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.